Found 47 matching trials
Early Access Program of Lazertinib in Republic of Korea N/A This early access program will be conducted to provide access to Lazertinib...
Show More Status
Approved For Marketing
Location
Multiple Locations
Learn More & Join Trial
A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker PHASE2 Using gefitinib or Osimertinib, an EGFR tyrosine kinase inhibitor (TKI), in...
Show More Location
The Catholic University of Korea, St. Vincent's Hospital
Learn More & Join Trial
A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult Participants PHASE1 The purpose of this study is to assess the extent of availability of drug t...
Show More Learn More & Join Trial
Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI PHASE2 AMAZE-lung is a multicenter single-arm phase II trial. The protocol treatme...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Impact of Lazertinib Dose Modification on Effectiveness and Safety N/A The primary objective is to evaluate Progression Free Survival (PFS) of the...
Show More Location
Inje University Busan Paik Hospital
Learn More & Join Trial
Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer PHASE2 In the randomized, multicenter Phase II clinical trial, we aim to evaluate ...
Show More Status
Active Not Recruiting
Location
Severance hospital
Learn More & Join Trial
A Study to Evaluate the Effect of Hepatic Impairment on Lazertinib (JNJ-73841937) PHASE1 The purpose of this study is to evaluate the pharmacokinetics (PK) of a sin...
Show More Location
CRS Clinical Research Services Kiel GmbH
Learn More & Join Trial
Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases PHASE2 The primary objective is to evaluate the intracranial efficacy of pemetrexe...
Show More Location
Gachon University Gil Medical Center
Learn More & Join Trial
Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI. PHASE2 This is an open-label, single-intervention, multicenter clinical trial in p...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior Lazertinib PHASE2 This trial is Phase II Trial of Lazertinib+Pemetrexed/Carboplatin in Patien...
Show More Status
Active Not Recruiting
Location
Yonsei University Health System, Severance Hospital
Learn More & Join Trial